Lipocortin-1 and the control of arachidonic acid release in cell signalling. Glucorticoids inhibit G protein-dependent activation of cPLA2 activity

Biochemical Pharmacology

Volumn 50, Issue 4, 1995, Pages 465-474

  Croxtall, Jamie D ^a   Choudhury, Qam ^a   Tokumoto, Hidekado ^b   Flower, Rod J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b ONO PHARMACEUTICAL CO   (Japan)

Author keywords

A549 cells; annexin 1; EGF; MAP kinase; thapsigargin; tyrosine kinase

Indexed keywords

CALCIUM; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; GUANOSINE 5' O (2 THIODIPHOSPHATE); GUANOSINE 5' O (3 THIOTRIPHOSPHATE); LIPOCORTIN 1; PERTUSSIS TOXIN; THAPSIGARGIN;

ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; HUMAN; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; TUMOR CELL;

AMINO ACID SEQUENCE; ANNEXIN I; ARACHIDONIC ACID; DEXAMETHASONE; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; GTP-BINDING PROTEINS; HUMAN; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHOSPHOLIPASES A; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; TERPENES; THAPSIGARGIN; TUMOR CELLS, CULTURED;

EID: 0029113114     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)00156-T     Document Type: Article

References (39)

1. Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line
2. N-terminal peptide fragments of lipocortin-1 inhibit A549 cell growth and block EGF-induced stimulation of proliferation
3. Mitogenic signaling by epidermal growth factor (EGF), but not platelet-derived growth factor, requires arachidonic acid metabolism in BALB/c3T3 cells
4. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids
5. 2 from human monocytic leukemic U937 cells
6. 2 from the human monocytic cell line U937
7. 2 is a 100-kDa protein in human monoblast U937 cells
8. 2-induced stimulation of A549 lung adenocarcinoma cell line proliferation
9. 2 activity by epidermal growth factor (EGF) in CHO cells transfected with EGF receptor
10. 2 in alveolar type II cells: biochemical and immunologie characterization
11. 1-adrenergic stimulation in FRTL5 thyroid cells
12. 2-specific pertussis toxin-inhibitable guanine nucleotide-binding regulatory protein in cultured rat inner medullary collecting tubule cells
13. Guanine nucleotide-binding protein stimulates arachidonic acid metabolism in TEA3A1 thymic epithelial cells by stimulating release and inhibiting incorporation of arachidonic acid
14. 2+-dependent translocation domain with homology to PKC and GAP
15. Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage
16. 1 cells
17. 2
18. Differential role of extra- and intracellular calcium in bradykinin and interleukin 1α stimulation of arachidonic acid release from A549 cells
19. 2+ influx by epidermal growth factor in A431 cells: effects of fluoride and bacterial toxins
20. 2 is coupled to hormonally regulated release of arachidonic acid
21. 2 is phosphorylated and activated by MAP kinase
22. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C
23. 2-adrenergic receptors expressed in fibroblasts
24. Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation
25. ras in activation of extracellular signal-regulated kinase 2
26. Multiple components in an epidermal growth factor-stimulated protein kinase cascade
27. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf
28. The MAP kinase cascade. Discovery of a new signal transduction pathway
29. Differential Raf requirement for activation of mitogen-activated protein kinase by growth factors, phorbol esters, and calcium
30. Antisense oligonucleotides to human lipocortin-1 inhibit glucocorticoid-induced inhibition of A549 cell growth and eicosanoid release
31. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test
32. Studies on the structural properties of lipocortin-1 and the regulation of its synthesis by steroids
33. Lipocortin-1 modifies the pyrogenic actions of cytokines in the rat
34. Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain
35. Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1
36. Epidermal growth factor-dependent phosphorylation of lipocortin
37. Lipocortins 1 and 2 as substrates for the insulin receptor kinase in rat liver.
38. Monoclonal antibodies to lipocortin-1 as probes for biological function
39. Characteristics of lipocortin 1 binding to the surface of human peripheral blood leukocytes